(VIANEWS) – Solar Capital Ltd. (SLRC), New York Community Bancorp (NYCB), Acco Brands Corporation (ACCO) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Solar Capital Ltd. (SLRC) | 10.77% | 2023-04-06 07:42:12 |
| New York Community Bancorp (NYCB) | 6.86% | 2023-03-30 07:48:17 |
| Acco Brands Corporation (ACCO) | 5.89% | 2023-04-13 03:09:08 |
| Cyclacel Pharmaceuticals (CYCCP) | 3.87% | 2023-04-02 15:10:08 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Solar Capital Ltd. (SLRC) – Dividend Yield: 10.77%
Solar Capital Ltd.’s last close was $14.62, 19.58% below its 52-week high of $18.18. Intraday change was -1.78%.
Solar Capital Ltd. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate sctivities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.
Earnings Per Share
As for profitability, Solar Capital Ltd. has a trailing twelve months EPS of $0.37.
PE Ratio
Solar Capital Ltd. has a trailing twelve months price to earnings ratio of 39.93. Meaning, the purchaser of the share is investing $39.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.59%.
Moving Average
Solar Capital Ltd.’s worth is under its 50-day moving average of $15.07 and above its 200-day moving average of $14.53.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 14, 2023, the estimated forward annual dividend rate is 1.64 and the estimated forward annual dividend yield is 10.77%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 31.2% and 16.2%, respectively.
More news about Solar Capital Ltd..
2. New York Community Bancorp (NYCB) – Dividend Yield: 6.86%
New York Community Bancorp’s last close was $9.14, 17.21% under its 52-week high of $11.04. Intraday change was 1.56%.
New York Community Bancorp, Inc. operates as a bank holding company for New York Community Bank that provides banking products and services in Metro New York, New Jersey, Ohio, Florida, and Arizona. The company offers various deposit products, including interest-bearing checking and money market, savings, non-interest-bearing, and individual retirement accounts, as well as certificates of deposit. It also provides multi-family loans; commercial real estate loans; specialty finance loans and leases, and other commercial and industrial loans; acquisition, development, and construction loans; one-to-four family loans; and consumer loans. In addition, the company offers annuities, life and long-term care insurance products, and mutual funds; cash management products; and online, mobile, and phone banking services. It primarily serves individuals, small and mid-size businesses, and professional associations through a network of 238 community bank branches and 348 ATM locations. The company was formerly known as Queens County Bancorp, Inc. and changed its name to New York Community Bancorp, Inc. in November 2000. New York Community Bancorp, Inc. was founded in 1859 and is headquartered in Westbury, New York.
Earnings Per Share
As for profitability, New York Community Bancorp has a trailing twelve months EPS of $1.11.
PE Ratio
New York Community Bancorp has a trailing twelve months price to earnings ratio of 8.23. Meaning, the purchaser of the share is investing $8.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.19%.
Yearly Top and Bottom Value
New York Community Bancorp’s stock is valued at $9.14 at 10:15 EST, way under its 52-week high of $11.04 and way higher than its 52-week low of $5.81.
Revenue Growth
Year-on-year quarterly revenue growth declined by 15%, now sitting on 1.35B for the twelve trailing months.
Sales Growth
New York Community Bancorp’s sales growth is 60.8% for the current quarter and 50.9% for the next.
More news about New York Community Bancorp.
3. Acco Brands Corporation (ACCO) – Dividend Yield: 5.89%
Acco Brands Corporation’s last close was $5.15, 35.71% below its 52-week high of $8.01. Intraday change was -1.15%.
ACCO Brands Corporation designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, calendars, planners, dry erase boards, and janitorial supplies; storage and organization products, such as three-ring and lever-arch binders, sheet protectors, and indexes; laminating, binding, and shredding machines; writing instruments; stapling and punching products; do-it-yourself tools; and computer accessories and others used in schools, homes, and businesses. It offers its products primarily under the AT-A-GLANCE, Barrilito, Derwent, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Marbig, Mead, NOBO, Quartet, Rapid, Rexel, Swingline, Tilibra, Spirax, and Wilson Jones brand names. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, drug/grocery, and variety chains; warehouse clubs; hardware and specialty stores; independent office product dealers; office superstores; wholesalers; and contract stationers, as well as sells products directly to commercial and consumer end-users through its e-commerce platform and direct sales organization. ACCO Brands Corporation was founded in 1893 and is headquartered in Lake Zurich, Illinois.
Earnings Per Share
As for profitability, Acco Brands Corporation has a trailing twelve months EPS of $-0.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.58%.
Volume
Today’s last reported volume for Acco Brands Corporation is 410897 which is 30.17% below its average volume of 588425.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Acco Brands Corporation’s EBITDA is 31.31.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 54.5% and a negative 18.9%, respectively.
More news about Acco Brands Corporation.
4. Cyclacel Pharmaceuticals (CYCCP) – Dividend Yield: 3.87%
Cyclacel Pharmaceuticals’s last close was $15.51, 31.31% under its 52-week high of $22.58. Intraday change was 0%.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise Sapacitabine, an orally available prodrug of CNDAC, which is a novel nucleoside analog. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
Earnings Per Share
As for profitability, Cyclacel Pharmaceuticals has a trailing twelve months EPS of $-2.05.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -80.34%.
Moving Average
Cyclacel Pharmaceuticals’s worth is way above its 50-day moving average of $13.90 and way higher than its 200-day moving average of $9.50.
Volume
Today’s last reported volume for Cyclacel Pharmaceuticals is 0 which is 100% below its average volume of 3679.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 19, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 3.87%.
More news about Cyclacel Pharmaceuticals.
